Welcome to IthaMaps
IthaMaps is a global epidemiology database of heamoglobinopathies, illustrating published data on a dynamic global to regional map. Country-specific information on haemoglobinopathy-related policies, prevalence, incidence and overall disease burden is given, including relative allele frequencies of specific globin mutations in each country and/or region, dynamically linked to corresponding IthaGenes entries.
IthaMaps content was supported by partnership with the HVP Global Globin 2020 Challenge
Search
General information for Albania
Albania |
|
---|
Haemoglobinopathy-specific healthcare policy information for Albania
Healthcare policy | Comment/Info | Reference | |
---|---|---|---|
Prevention programme: | No | Pilot study on β-thalassaemia carrier screening. | [PMID: 19556751] |
SCD newborn screening: | No | There is no official NBS programme. | [PMID: 33808002] |
Prenatal screening: | No | [PMID: 19556751] | |
Blood transfusion availability: | Yes (Regional) | Thalassemia Center in Lushnjë; limited availablity, based mainly on blood donations. | |
Patient associations: | Yes (National) | e.g.: Albanian Thalassaemics Association (ATA). |
Prevalence and incidence of major haemoglobinopathies in Albania
Haemoglobinopathy | Comment/Info | Reference | |
---|---|---|---|
Prevalence of β-thalassaemia carriers: | 5 % of the population | [PMID: 24672827] | |
Prevalence of sickle cell disease carriers: | 1.4 % of the population | [PMID: 24672827] | |
Expected incidence of β-thalassaemia: | 18 expected affected births/year | [PMID: 24672827] | |
Incidence of sickle cell disease: | 30 affected births/year | Median value estimated using statistical model and demographic data. | [PMID: 23103089] |
Known β-thalassaemia patients: | 500 patients | [PMID: 24672827] | |
Known sickle cell disease patients: | 530 patients | [PMID: 24672827] |
Global Burden of Disease data for Albania
Migration data for Albania
Mutation frequencies in Albania
Overview (most frequent mutations with their observed average values and range)
β-locus
IVS I-110 G>A: 43.35 % (43.2 % – 43.5 %) | CD 39 CAG>TAG [Gln>STOP]: 19.53 % (16.66 % – 22.4 %) |
IVS I-6 (T>C): 17.85 % (17.2 % – 18.5 %) | IVS I-1 G>A: 6.76 % (5.2 % – 8.33 %) |
Detailed mutation frequencies
Entry ID | Locus | Region | Ethnic Group | Population Type | Sample Size | Study period (from) | Study period (to) | Reference | Comments | |
---|---|---|---|---|---|---|---|---|---|---|
23120 | β-locus | Southwest | Albanian | Carriers and Patients | 144 | 2011 | 24052702 | Frequencies are shown for beta-globin gene mutations. Study samples were acquired from the University Hospital in Tirana, and the majority were from districts in southwest Albania. | ||
23121 | β-locus | Southwest | Albanian | Patients | 58 | 1994 | 8112743 | Frequencies are shown for beta-globin gene mutations. Study samples were acquired from the University Hospital in Tirana, and the majority were from districts in southwest Albania. |
Organisations in Albania
A list of all organisations in Albania stored in the ITHANET database is shown below. For more information, click on the corresponding organisation name or visit the detailed ITHANET Organisations page
Name | Department | Organisation type |
---|---|---|
Institute of Pediatrics | Center of Hemoglobinopathies, Department of Clinical Biochemistry | Research Center, Medical Center |
Microattributions
No microattibutions were provided for Albania. Please contact us, if you are willing to review existing information or provide new data.
To provide new epidemiological information and/or report mistakes, please register/log in first or use the Contact Us form.
Important Note: The relative allele frequencies presented in IthaMaps are not calculated by ITHANET, but they are extracted from the corresponding publications. ITHANET is not responsible for any mistakes in the data. Please use this information with caution! We encourage scientists that have more detailed or updated epidemiological information to contact us.
Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaMaps are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.